Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Clinical Science (London, England : 1979)
|
November 14, 2019
A tangled tale of microRNA and cardiac fibrosis
Mark Chandy
Toxicology and Applied Pharmacology
|
December 16, 2023
Recent advances in the cardiotoxicity of anti-cancer drugs: Navigating the landscape of anthracycline-induced cardiotoxicity
Mark Chandy, Daniel J Conklin
EMBO Molecular Medicine
|
October 26, 2022
Elucidating effects of environmental exposure using human-induced pluripotent stem cell disease modeling
Mark Chandy, Detlef Obal, Joseph C Wu
Pharmacological Reviews
|
December 25, 2019
Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
David T Paik, Mark Chandy, Joseph C Wu
Nature Reviews. Cardiology
|
January 23, 2025
The relationship between cannabis and cardiovascular disease: clearing the haze
Mark Chandy, Nerea Jimenez-Tellez, Joseph C Wu
Acta Physiologica (Oxford, England)
|
October 24, 2024
The effects of cannabinoids on the kidney
Steven Didik, Oleg Palygin, Mark Chandy, et al.
Current Opinion in Lipidology
|
March 2, 2023
Exosomes and lipid metabolism in metabolic and cardiovascular disorders
Zina Zein Abdin, Apple Ziquan Geng, Mark Chandy
Case Reports in Cardiology
|
September 22, 2016
Delayed Tamponade after Traumatic Wound with Left Ventricular Compression
Fahad Almehmadi, Mark Chandy, Kim A Connelly, et al.
Eukaryotic Cell
|
October 13, 2006
SWI/SNF displaces SAGA-acetylated nucleosomes
Mark Chandy, José L Gutiérrez, Philippe Prochasson, et al.
Trends in Pharmacological Sciences
|
August 28, 2025
Cardiac fibrosis: from mechanisms and models to medicines
Wenqiang Liu, Xuekun Wu, Wenshu Zeng, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Clinical Science (London, England : 1979)
|
November 14, 2019
A tangled tale of microRNA and cardiac fibrosis
Mark Chandy
Toxicology and Applied Pharmacology
|
December 16, 2023
Recent advances in the cardiotoxicity of anti-cancer drugs: Navigating the landscape of anthracycline-induced cardiotoxicity
Mark Chandy, Daniel J Conklin
EMBO Molecular Medicine
|
October 26, 2022
Elucidating effects of environmental exposure using human-induced pluripotent stem cell disease modeling
Mark Chandy, Detlef Obal, Joseph C Wu
Pharmacological Reviews
|
December 25, 2019
Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
David T Paik, Mark Chandy, Joseph C Wu
Nature Reviews. Cardiology
|
January 23, 2025
The relationship between cannabis and cardiovascular disease: clearing the haze
Mark Chandy, Nerea Jimenez-Tellez, Joseph C Wu
Acta Physiologica (Oxford, England)
|
October 24, 2024
The effects of cannabinoids on the kidney
Steven Didik, Oleg Palygin, Mark Chandy, et al.
Current Opinion in Lipidology
|
March 2, 2023
Exosomes and lipid metabolism in metabolic and cardiovascular disorders
Zina Zein Abdin, Apple Ziquan Geng, Mark Chandy
Case Reports in Cardiology
|
September 22, 2016
Delayed Tamponade after Traumatic Wound with Left Ventricular Compression
Fahad Almehmadi, Mark Chandy, Kim A Connelly, et al.
Eukaryotic Cell
|
October 13, 2006
SWI/SNF displaces SAGA-acetylated nucleosomes
Mark Chandy, José L Gutiérrez, Philippe Prochasson, et al.
Trends in Pharmacological Sciences
|
August 28, 2025
Cardiac fibrosis: from mechanisms and models to medicines
Wenqiang Liu, Xuekun Wu, Wenshu Zeng, et al.
Page
of 4